1/5
Looks like no tags are added yet.
therapeutic window for tacrolimus based on CYP3A5
4 -11 ng/mL
what is used for immunosuppression?
Calcineurin inhibitor
supratherapeutic side effects of tacrolimus
nephrotoxicity
HTN
neurotoxicity
hyperglycemia
therapeutic plan for tacrolimus based on CYP3A5

what is plasma concentration of tacrolimus for a CYP3A5 poor metabolizer
within therapeutic levels, intitiate w/ standard recommended dose
T or F: pts w/ CYP3A5 WT allele generally require lower doses of tacrolimus
false → increase 1.5x recommended starting dose